Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Morrow George J sold 15,000 Neurocrine Biosciences, Inc. shares (Form 4)
Traded Oct 30 to Nov 3, 2026 · Filed Nov 3, 2026
From Oct 30 to Nov 3, 2026, Morrow George J (Director) sold 15,000 Neurocrine Biosciences, Inc. shares at an average US$155.73 for US$2.34M under a trading plan, leaving 10,386 shares. Filed Nov 3, 2026 (Form 4).
- Sold
- 15,000 shares
- Price
- US$155.73 average (US$144.98 to US$168.53)
- Value
- US$2.34M
- Holding after
- 10,386 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Common Stock | Option exercise | 300 | US$53.64 | 10,686 | Direct |
| Oct 30, 2026 | Common Stock | Sale | 300 | US$149.00 | 10,386 | Direct |
| Nov 2, 2026 | Common Stock | Option exercise | 7,500 | US$53.64 | 17,886 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,900 | US$144.98 | 15,986 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 4,300 | US$145.86 | 11,686 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 1,300 | US$146.76 | 10,386 | Direct |
| Nov 3, 2026 | Common Stock | Option exercise | 7,200 | US$53.64 | 17,586 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 100 | US$158.18 | 17,486 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 100 | US$162.05 | 17,386 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 600 | US$163.71 | 16,786 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 1,226 | US$164.74 | 15,560 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 908 | US$165.71 | 14,652 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 1,466 | US$166.77 | 13,186 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 1,500 | US$167.72 | 11,686 | Direct |
| Nov 3, 2026 | Common Stock | Sale | 1,300 | US$168.53 | 10,386 | Direct |
Source
Download original · View original at SEC
Related
- Neurocrine Biosciences, Inc.
- Morrow George J
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Morrow George J · May 21, 2026
- Form 4 · Lyons Gary A · Nov 19, 2026
- Form 4 · Gano Kyle · Nov 3, 2026
- Schedule 13G · Vanguard Portfolio Management LLC · Oct 30, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026